SUBSTITUTED TETRAHYDROFURANS AS MODULATORS OF SODIUM CHANNELS

Compounds, and pharmaceutically acceptable salts thereof, useful as inhibitors of sodium channels are provided. Also provided are pharmaceutical compositions comprising the compounds or pharmaceutically acceptable salts and methods of using the compounds, pharmaceutically acceptable salts, and pharm...

Full description

Saved in:
Bibliographic Details
Main Authors PULLIN, ROBERT, GALAN, BHAIRAVI, SCHMIDT, YVONNE, SHAW, DAVID MATTHEW, AHMAD, NADIA, HURLEY, DENNIS JAMES, DURRANT, STEVEN JOHN, NEUBERT, TIMOTHY DONALD, THOMSON, STEPHEN ANDREW, VIRANI, ANISA NIZARALI, PONTILLO, JOSEPH, CHUDYK, EWA IWONA, ETXEBARRIA JARDI, GORKA, HADIDA RUAH, SARA S, SKERRATT, SARAH, PINDER, JOANNE LOUISE, BECK, ELIZABETH MARY, KNEGTEL, RONALD MARCELLUS, STAMOS, DEAN, CARVALHO, MEIRLES LIDIO, WRAY, CHRISTOPHER
Format Patent
LanguageEnglish
French
Published 10.06.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Compounds, and pharmaceutically acceptable salts thereof, useful as inhibitors of sodium channels are provided. Also provided are pharmaceutical compositions comprising the compounds or pharmaceutically acceptable salts and methods of using the compounds, pharmaceutically acceptable salts, and pharmaceutical compositions in the treatment of various disorders, including pain. L'invention concerne des composés, et des sels pharmaceutiquement acceptables de ceux-ci, utiles en tant qu'inhibiteurs de canaux sodiques. L'invention concerne également des compositions pharmaceutiques comprenant les composés ou des sels pharmaceutiquement acceptables et des procédés d'utilisation des composés, des sels pharmaceutiquement acceptables, et des compositions pharmaceutiques dans le traitement de divers troubles, y compris la douleur.
Bibliography:Application Number: CA20203164134